GC Green Cross Presents "Strategies to Enhance Accessibility for Plasma Fractionated Product Supply"

Emphasizing the Importance of Stable Raw Plasma Procurement

GC Green Cross announced on September 8 that it gave a presentation on "Strategies to Enhance Accessibility for Sustainable Plasma Fractionated Product Supply" at the 2025 Global Bio Conference (GBC) held at the Grand InterContinental Parnas in Seoul on September 5.

Jaewoo Lee, Head of Development at GC Green Cross, attended the 2025 Global Bio Conference (GBC) on the 5th and gave a presentation on the topic of "Strategies to Enhance Accessibility for Sustainable Plasma Fractionation Supply." GC Green Cross

The GBC is an event hosted by the Ministry of Food and Drug Safety, where global biopharmaceutical industry experts and leaders gather to share the latest insights in the field.

During the presentation, GC Green Cross emphasized that the key to a sustainable plasma fractionated product business is the stable procurement of raw plasma. In Korea, the plasma self-sufficiency rate has fallen below 50% since 2021 due to a decline in blood donors. During the COVID-19 pandemic, the global volume of blood donations also plummeted, causing the price of raw plasma to surge. As a result, the global supply shortage of plasma fractionated products became more severe at that time.

Although blood donation volumes have been recovering since the transition to the COVID-19 endemic phase, domestic donations still fall short of meeting rising demand, leading to an even greater reliance on expensive imported plasma for pharmaceutical manufacturing.

GC Green Cross explained that it is working to address this issue by diversifying the countries from which it imports raw plasma and strengthening its supply chain. In addition, since all domestic plasma fractionated products have been designated as essential medicines by the government, the company stressed the need for close collaboration between the government and industry on key decisions, such as easing raw plasma management standards and providing reimbursement to ensure cost recovery.

Jaewoo Lee, Head of Development at GC Green Cross, who delivered the presentation, stated, "We are making company-wide efforts to establish a sustainable plasma fractionated product supply system," and added, "We will do our utmost to work closely with the government to prevent any domestic supply shortages."

This content was produced with the assistance of AI translation services.